Hello, and welcome to TechScape. I’m your host, Blake Montgomery. If you enjoy reading this newsletter, please forward it to someone you think would as well. The US-Israel war on Iran shows that datacenters are a new frontier in warfare Iran is bombing datacenters in the Persian Gulf to blow up symbols of the Gulf states’ technological alliance with the United States. Added bonus: they will be ext...
Hello, and welcome to TechScape. I’m your host, Blake Montgomery. If you enjoy reading this newsletter, please forward it to someone you think would as well. The US-Israel war on Iran shows that datacenters are a new frontier in warfare Iran is bombing datacenters in the Persian Gulf to blow up symbols of the Gulf states’ technological alliance with the United States. Added bonus: they will be extremely costly to rebuild, being among the most expensive buildings in history. My colleague Daniel Boffey reports: It is believed to be a first: the deliberate targeting of a commercial datacenter by the armed forces of a country at war. At 4.30am on Sunday morning, an Iranian Shahed 136 drone struck an Amazon Web Services datacenter in the United Arab Emirates, setting off a devastating fire and forcing a shutdown of the power supply. Further damage was inflicted as attempts were made to suppress the flames with water. Soon after, a second datacenter owned by the US tech company was hit. Then a third was said to be in trouble, this time in Bahrain, after an Iranian suicide drone turned to fireball on striking land nearby. Iranian state TV has claimed that Iran’s Islamic Revolutionary Guard Corps launched the attack “to identify the role of these centers in supporting the enemy’s military and intelligence activities”. The coordinated strike had an immediate impact. Millions of people in Dubai and Abu Dhabi woke up on Monday unable to pay for a taxi, order a food delivery or check their bank balance on their mobile apps. Whether there was a military impact is unclear – but the strikes swiftly brought the war directly into the lives of 11 million people in the UAE, nine out of 10 of whom are foreign nationals. Amazon has advised its clients to secure their data away from the region. Read more: ‘It means missile defence on datacentres’: drone strikes raise doubts over Gulf as AI superpower The Guardian view on AI and war View image in fullscreen Photograph: Alexander Drago/Reu...
Nokian provided flights from Austin, Texas, to Ivalo, Finland, and accommodation so Ars could visit its test facility. Ars does not accept paid editorial content. IVALO, Finland—In 1987, fictional superspy James Bond careened around a frozen lake in an Aston Martin in the movie The Living Daylights . Bond’s tires were carrying a secret—retractable tire studs that operated with the touch of a butto...
Nokian provided flights from Austin, Texas, to Ivalo, Finland, and accommodation so Ars could visit its test facility. Ars does not accept paid editorial content. IVALO, Finland—In 1987, fictional superspy James Bond careened around a frozen lake in an Aston Martin in the movie The Living Daylights . Bond’s tires were carrying a secret—retractable tire studs that operated with the touch of a button. After cutting a circle in the ice with a wheel to sink the bad guys, Bond deployed his outriggers for balance and his on-demand studs for an impressive getaway. Nokian Tires played with that idea, presenting a concept in 2014 with similar functionality. However, as Nokian development manager Mikko Liukkula remembers wryly, each tire was so complex that a production set would have cost more than the vehicle itself. Fast-forward to 2026, and Nokian has debuted a giant step forward in studded-tire engineering: a studded winter tire that automatically adjusts to changes in temperature and surface pressure. I put these new Hakkapeliitta 01 tires through the wringer in and around a frozen-over Lake Tammijärvi at Nokian’s 1,700-acre testing center. After drifting, slaloming, hard braking, and swooshing along snowy trails, I can attest to the quality of the gripping power. Read full article Comments
Bill Oxford Citing a congressional investigation, The Wall Street Journal reported on Tuesday that due to alleged overpayments to Medicare Advantage health plans, Medicare Part B premiums increased by $13.4 billion last year, with most of that cost borne by seniors. Those additional costs affected beneficiaries of Medical Advantage plans as well as those enrolled in standard Medicare plans, accord...
Bill Oxford Citing a congressional investigation, The Wall Street Journal reported on Tuesday that due to alleged overpayments to Medicare Advantage health plans, Medicare Part B premiums increased by $13.4 billion last year, with most of that cost borne by seniors. Those additional costs affected beneficiaries of Medical Advantage plans as well as those enrolled in standard Medicare plans, according to the investigation conducted by the Joint Economic Committee. The bipartisan group of lawmakers representing the Senate and the House is led by Rep. David Schweikert (R., Ariz.). The committee found that the average American senior’s Medicare premiums rose about 10%, or more than $200 annually, due to the alleged overpayments last year. The premium hike was partly attributed to a controversial tactic health insurers use to add payment-boosting diagnoses for Medicare Advantage members. The additional spending on Medicare Advantage “is not just coming out of the federal government’s budget,” Schweikert said, adding, “A portion of this comes out of you.” America’s Health Insurance Plans (AHIP), which represents health insurers, denied the allegations. The committee’s findings were based on “fundamentally flawed data, methodology, and extrapolations” and shouldn’t dictate policy, WSJ reported, citing a spokesperson for AHIP. UnitedHealth ( UNH ) is the biggest player in the MA market, followed by Humana ( HUM ). CVS Health’s ( CVS ) Aetna unit, Clover Health ( CLOV ), and Alignment Healthcare ( ALHC ) are among other MA operators. More on UnitedHealth, Humana, etc. CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript CVS Health: Stop Catastrophizing, Start Believing - Here's Why UnitedHealth: A Golden Buying Opportunity (Rating Upgrade) Top 10 healthcare stocks with highest dividend yield amid volatile markets Insurer Humana prices $1B junior subordinated notes offering due 2056
Gervase de Wilde, for Aluko, said that in the two X posts Barton, from Huyton, had wrongly claimed she had "cynically sought to exploit her status as an alleged victim of racism and bullying", and that she was a hypocrite.
Gervase de Wilde, for Aluko, said that in the two X posts Barton, from Huyton, had wrongly claimed she had "cynically sought to exploit her status as an alleged victim of racism and bullying", and that she was a hypocrite.
The judge accepted that Hayes did "join in" on two occasions by using the word potato or the potato emoji in messages, but that she did it to "fit in" and "make it seem OK".
The judge accepted that Hayes did "join in" on two occasions by using the word potato or the potato emoji in messages, but that she did it to "fit in" and "make it seem OK".
(RTTNews) - Maple Leaf Foods Inc. (MLFNF, MFI.TO) announced Tuesday its financial targets for 2030, expecting growth in revenues and adjusted EBITDA. The consumer packaged goods company plans to reveal additional details on its 2030 financial targets, strategic Blueprint, and growth initiatives at its Investor Day later today. For fiscal 2030, the company expects revenue to grow to approximately C...
(RTTNews) - Maple Leaf Foods Inc. (MLFNF, MFI.TO) announced Tuesday its financial targets for 2030, expecting growth in revenues and adjusted EBITDA. The consumer packaged goods company plans to reveal additional details on its 2030 financial targets, strategic Blueprint, and growth initiatives at its Investor Day later today. For fiscal 2030, the company expects revenue to grow to approximately C$5 billion, driven by proven growth platforms. Adjusted EBITDA is expected to be around C$750 million, reflecting the benefits of revenue growth and structurally higher margins over time. In fiscal 2025, sales were C$3.91 billion and adjusted EBITDA was C$475.7 million, with adjusted EBITDA margin of 12.2%, all higher than the previous year. In the core business, the company aims to deliver organic mid-single-digit revenue expansion through its growth platforms in 2030. The company also projects to grow profits approximately twice as fast as revenue, reflecting the benefits of both revenue growth and structurally higher margins over time. Maple Leaf Foods noted that since 2021, revenue has grown by approximately 5% on a compounded annual basis, and Adjusted EBITDA margin expanded by 630 basis points to 12.2% in 2025 from 5.9%. The company added that cumulative free cash flow over the 2026 to 2030 five-year period would be approximately C$1.7 billion to C$1.8 billion, scaling in line with profit growth. Curtis Frank, President and Chief Executive Officer, said, "Execution of our strategic Blueprint has delivered consistent revenue growth, expanded margins, and a strong balance sheet.... With our major investments in new facilities complete, we are positioned to accelerate profitable growth and generate significant free cash flow." In Toronto, Maple Leaf Foods shares closed Monday's regular trading at C$28.60, up 0.32 percent. In OTC, MLFNF traded on Monday at $20.41, down 3.18 percent. The views and opinions expressed herein are the views and opinions of the author and do no...
"But we are standing firm until the end to survive and to be free. Even if we are killed, it honestly does not matter compared to the lives that have already been lost in the hope of victory," she said.
"But we are standing firm until the end to survive and to be free. Even if we are killed, it honestly does not matter compared to the lives that have already been lost in the hope of victory," she said.
thamerpic/iStock Editorial via Getty Images Our team is back to analyse Zurich Insurance Group ( ZURVY ) ( ZFSVF ), which released its Annual 2025 results on 5 March 2026. Since our deep dive (Q3 results), the company's shares are down 0.81% (Fig. 1). This was mainly due to the Beazley acquisition and Zurich's new share placement, which raised a total of CHF 3.9 billion (approximately $5 billion) ...
thamerpic/iStock Editorial via Getty Images Our team is back to analyse Zurich Insurance Group ( ZURVY ) ( ZFSVF ), which released its Annual 2025 results on 5 March 2026. Since our deep dive (Q3 results), the company's shares are down 0.81% (Fig. 1). This was mainly due to the Beazley acquisition and Zurich's new share placement, which raised a total of CHF 3.9 billion (approximately $5 billion) in proceeds. The company issued 7,090,909 new registered shares at a price of CHF 550, and given that, we are not surprised that its share price has declined accordingly. Mare Ev. Lab Rating Update Fig. 1 Zurich Insurance Results and Our Positive Take The company reported a net profit and ROE of +17% (vs. 2024 numbers) and 26.9%, respectively. Zurich's performance was backed by its internal cash cow, i.e., the Property & Casualty division. The P&C segment delivered operating profit exceeding $5 billion (Fig. 3), driven by a lower combined ratio (a 160-basis-point reduction vs. 2024 numbers). The Life business also reported underlying growth of 10%, thanks to its contractual service margin release. Lastly, the Farmers' business ( Zurich's former Achilles' heel ) delivered its strongest operating profit, up 4% to $2.38 billion. Zurich Insurance net income evolution Fig. 2 Zurich Insurance BOP by segment Source: Zurich Insurance Q4 results ppt —Fig. 3 Why Are We Positive? Our readers know that our equity story is supported by new evidence in every analysis. This time, we see support from 1) solid execution with tailwinds from insurance products by individuals in retirement and savings and 2) the Beazley acquisition. Aside from record-breaking results across nearly all key metrics (Fig. 4), Life's new business CSM increased 13%, with fees from investment contracts up 17%. Retail savings, protection, and unit-linked products supported the Life division. Farmers RE’s BOP of $243 million significantly outpaced our internal forecast, proving that the corrective actions in the US ar...
Trinity Capital ( TRIN ) on Tuesday said it has committed $35 million in growth capital to Neuros Medical. The financing will support the expansion and commercialization of Neuros Medical’s Altius Direct Electrical Nerve Stimulation System, which is designed to treat chronic post-amputation pain. Neuros Medical said the funding will also help scale adoption of the therapy and support expansion int...
Trinity Capital ( TRIN ) on Tuesday said it has committed $35 million in growth capital to Neuros Medical. The financing will support the expansion and commercialization of Neuros Medical’s Altius Direct Electrical Nerve Stimulation System, which is designed to treat chronic post-amputation pain. Neuros Medical said the funding will also help scale adoption of the therapy and support expansion into new markets. TRIN +1.41% premarket to $15.07. Source: Press Release More on Trinity Capital Trinity Capital: Strong Investment Setup (Rating Upgrade) Trinity Capital: Not Your Typical 13%+ Yielding BDC Trinity Capital: NAV Growth Continues In Q4 Trinity Capital outlines $1.2B in unfunded commitments and monthly dividend transition amid robust portfolio growth Trinity Capital posts preliminary Q4, full-year 2025 results